Skip to main content
. 2012 Mar;97(3):442–450. doi: 10.3324/haematol.2011.043372

Figure 4.

Figure 4

(A) Progression-free survival and (B) overall survival according to induction therapy regimen in patients with a favorable interphase FISH. (C) Progression-free survival and (D) overall survival according to induction therapy regimen in patients with an adverse interphase FISH (intent-to-treat analysis). FISH: fluorescence in situ hybridization.